Cargando…
Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone
This population-based retrospective cohort study investigated dementia risk associated with acarbose in patients with type 2 diabetes mellitus by using Taiwan’s National Health Insurance database. A cohort of 15,524 matched pairs of ever and never users of acarbose based on propensity score matching...
Autor principal: | Tseng, Chin-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220278/ https://www.ncbi.nlm.nih.gov/pubmed/32489710 http://dx.doi.org/10.14336/AD.2019.0621 |
Ejemplares similares
-
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019) -
Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
por: Tseng, Chin-Hsiao
Publicado: (2018) -
Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014) -
Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
por: Chen, Yu-Hsin, et al.
Publicado: (2016) -
Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)